Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Obstructive lung disease
Disease management
DOI:
10.1111/resp.13012
Publication Date:
2017-02-02T07:27:04Z
AUTHORS (22)
ABSTRACT
This Executive Summary of the Global Strategy for Diagnosis, Management and Prevention COPD, Initiative Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on revised novel parts document. The most significant changes include: (i) assessment chronic obstructive pulmonary disease has been refined to separate spirometric from symptom evaluation. ABCD groups are now proposed be derived exclusively patient symptoms their history exacerbations; (ii) each A D, escalation strategies pharmacological treatments proposed; (iii) concept de-escalation therapy is introduced in treatment scheme; (iv)non-pharmacological therapies comprehensively presented (v) importance co-morbid conditions managing COPD reviewed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (339)
CITATIONS (262)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....